|
|
|
|
|
|
|
|
|
|
|
 indicates items that take place in your region |
|
|
 Annual Meeting | |
|
|
 eLearning | |
|
Clinical Investigator: Module 1 - Study Preparation and Initiation - (Feb 09, 2010) - Online
|
Clinical Investigator: Module 2 - Conducting The Study - (Feb 09, 2010) - Online
|
Crisis Management - (Feb 09, 2010) - Online
|
Database Management - (Feb 09, 2010) - Online
|
Literature Evaluation - (Feb 09, 2010) - Online
|
Literature Searching - (Feb 09, 2010) - Online
|
Medical Inquires - (Feb 09, 2010) - Online
|
Medical Writing - (Feb 09, 2010) - Online
|
Product Labeling - (Feb 09, 2010) - Online
|
Regulatory Issues - (Feb 09, 2010) - Online
|
History of US Drug Regulation - (Feb 09, 2010) - Online
|
Informed Consent - (Feb 09, 2010) - Online
|
Statistics for Medical Communications Professionals - (Feb 09, 2010) - Online
|
|
|
 EudraVigilance | |
|
EudraVigilance: Medicinal Product Dictionary - (Feb 16, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Feb 17, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Mar 03, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Mar 17, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Mar 29, 2010) - Lisboa
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Apr 12, 2010) - London
|
EudraVigilance & Electronic Reporting of ICSRs in the EEA - (Apr 19, 2010) - Horsham
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Apr 26, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (May 03, 2010) - Madrid
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (May 17, 2010) - London
|
EudraVigilance: Medicinal Product Dictionary - (May 25, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (May 26, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Jun 09, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Jun 14, 2010) - London
|
EudraVigilance Information Day - (Jun 22, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Jun 28, 2010) - San Marino
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Jul 05, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Sep 01, 2010) - London
|
EudraVigilance: Medicinal Product Dictionary - (Sep 14, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Sep 15, 2010) - London
|
EudraVigilance: Electronic Reporting of ICSRs in the EEA - (Sep 20, 2010) - Paris
|
EudraVigilance - Electronic Reporting of ICSRs in the EEA - (Sep 29, 2010) - Vienna
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Oct 13, 2010) - London
|
EudraVigilance Information Day - (Oct 19, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Oct 20, 2010) - London
|
EudraVigilance & Electronic Reporting of ICSRs in the EEA - (Oct 25, 2010) - Horsham
|
EudraVigilance: Medicinal Product Dictionary - (Nov 09, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Nov 10, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Nov 17, 2010) - London
|
Eudravigilance - Electronic Reporting of ICSRs in the EEA - (Dec 15, 2010) - London
|
|
|
 Euro Meeting | |
|
|
 Meeting | |
|
23rd Annual DIA Conference for Electronic Document Management: Global Content Management in an Electronic World - (Feb 16, 2010) - National Harbor
|
Pharmacovigilance and Risk Management - (Feb 20, 2010) - Chennai
|
22nd Annual Conference on Marketing Pharmaceuticals: Integrated Marketing, Emerging Media Trends, and New Regulations - (Feb 23, 2010) - New York
|
Liability Risks in Clinical Trials - (Feb 25, 2010) - Washington
|
DIA/FDA/PVRI Debate on Clinical Trials for Pulmonary Arterial Hypertension - (Mar 02, 2010) - North Bethesda
|
2nd AFRICAN REGULATORY CONFERENCE A forum for regulatory authorities and the pharmaceutical industry - (Mar 02, 2010) - Johannesburg
|
Early Drug Development: Navigating the Treacherous Rapids - (Mar 03, 2010) - Bethesda
|
21st Annual Workshop on Medical Communications: Defining the Future of Medical Communications - (Mar 14, 2010) - Scottsdale
|
CTD Dossier Requirements Focus on EU Module 1 and Quality Module 3 - (Mar 21, 2010) - Mumbia
|
DIA/FDA CDER/CBER Computational Science Annual Meeting - (Mar 22, 2010) - North Bethesda
|
3rd Oligonucleotides-based Therapeutics Conference - (Mar 23, 2010) - Bethesda
|
Evidence-based Medicine & Health Technology Assessment: Moving From Separate Appraisals to Synergistic Communications - (Mar 23, 2010) - WASHINGTON
|
CTD Dossier Requirements: Focus on EU Module 1 and Quality Module 3 - (Mar 24, 2010) - Hyderabad
|
FDA Guidance on Adaptive Design for Clinical Trials - (Mar 26, 2010) - Silver Spring
|
Cardiovascular Safety in Drug Development: QT, Arrhythmias, Thrombosis, and Bleeding - (Apr 11, 2010) - Arlington
|
Clinical Development of Stem Cell Therapies: Scientific, Regulatory and Ethical Considerations - (Apr 12, 2010) - North Bethesda
|
The 4th Annual Conference in Japan for Asian New Drug Development - (Apr 13, 2010) - Tokyo
|
4th Annual FDA/DIA Statistics Forum - (Apr 18, 2010) - North Bethesda
|
4th European Forum for Qualified Person for Pharmacovigilance (QPPV) - (Apr 21, 2010) - London
|
DIA and FDA Office of Women’s Health (OWH): Strategies for Ensuring Representation of Patient Demographics in Clinical Research for Regulatory Review - (May 05, 2010)
|
3rd Annual Regulatory Conference on “Global Regulatory Challenges: Quest for Optimization - (May 07, 2010) - Andheri East
|
2nd DIA China Annual Meeting - (May 16, 2010)
|
The 1st DIA Cardiac Safety Workshop in Japan - (May 25, 2010) - Tokyo
|
DIA European Regulatory Affairs Forum 2010 - (May 31, 2010)
|
Workshop on Statistical Methodology in Clinical R&D - (Sep 27, 2010) - Vienna
|
4th Annual Clinical Forum 2010 - (Oct 11, 2010) - Lisboa
|
Innovation Forum - (Nov 29, 2010)
|
11th Conference on European Electronic Document Management - (Dec 01, 2010) - Nice
|
|
|
 Training Course | |
|
European Regulatory Affairs - (Feb 15, 2010) - Lisbon
|
Pre-marketing Clinical Safety & Pharmacovigilance - (Feb 16, 2010) - Horsham
|
Post-marketing Drug Safety & Pharmacovigilance - (Feb 18, 2010) - Horsham
|
European Regulatory Affairs - (Feb 22, 2010) - San Francisco
|
Overview of Drug Development - (Feb 26, 2010) - Horsham
|
Fundamentals of Clinical Research Monitoring - (Mar 01, 2010) - Horsham
|
Introduction to Good Clinical Practices and Auditing - (Mar 01, 2010) - Horsham
|
Clinical Statistics for Nonstatisticians - (Mar 04, 2010) - Horsham
|
Computer Systems Validation for the Non-computer Professional - (Mar 04, 2010) - Horsham
|
Leadership Experience - (Mar 08, 2010) - Bethesda
|
Regulatory Affairs Part II: The NDA Phase - (Mar 08, 2010) - Horsham
|
Regulatory Affairs for Biologics - (Mar 11, 2010) - Horsham
|
Overview of Drug Development in Japan - (Mar 11, 2010) - Horsham
|
Utilizing Chemistry, Manufacturing & Control (CMC) in Drug Development - (Apr 08, 2010) - Horsham
|
Development of a Clinical Study Report - (Apr 16, 2010) - Horsham
|
Essentials of Project Management - (Apr 19, 2010) - Horsham
|
Introduction to Portfolio Management and Performance Metrics - (Apr 20, 2010) - Horsham
|
Project Information, Communication, and Knowledge Management - (Apr 22, 2010) - Horsham
|
High Performance Biopharm Teams - (Apr 22, 2010) - Horsham
|
CTD Dossier Requirements: Focus on EU Module 1 and Quality Module 3 - (Apr 26, 2010) - Vienna
|
Good Management of Medical Devices - (Apr 26, 2010) - Paris
|
An Introduction to Product Information Management (PIM) - (Apr 26, 2010) - Vienna
|
Introduction to Signal Detection and Data Mining in Pharmacovigilance in Europe - (Apr 26, 2010) - Paris
|
How to Prepare for Pharmacovigilance - Audits and Inspections in Europe - (Apr 27, 2010) - Paris
|
New Drug Product Development & Lifecycle Management - (Apr 29, 2010) - Horsham
|
Drug Safety Surveillance and Epidemiology - (May 03, 2010) - Horsham
|
Essentials of Clinical Study Management - (May 05, 2010) - Vienna
|
Introduction to Signal Detection and Data Mining - (May 05, 2010) - Horsham
|
How to Prepare for a Safety Inspection - (May 06, 2010) - Horsham
|
Risk Management and Communication to Optimize Medicinal Product Safety - (May 06, 2010) - Horsham
|
Practical Guide for Pharmacovigilance: Clinical Trials and Post Marketing - (Jun 02, 2010) - Prague
|
European Regulatory Affairs - (Jun 03, 2010) - Prague
|
Advanced GCP Study Monitoring - (Jun 04, 2010) - Prague
|
Leadership Experience - (Aug 09, 2010) - Boston
|
Regulatory Affairs Part I: The IND Phase and Part II: The NDA Phase - (Aug 09, 2010) - Boston
|
European Regulatory Affairs - (Aug 09, 2010) - Horsham
|
Clinical Statistics for Nonstatisticians - (Sep 13, 2010) - Paris
|
Medical Approach in Diagnosis and Management of ADRs - (Sep 13, 2010) - Boulogne-Billancourt (Paris)
|
Regulatory Affairs Part I: The IND Phase - (Sep 13, 2010) - Horsham
|
Drug Safety Surveillance and Epidemiology - (Sep 20, 2010) - Horsham
|
Clinical Project Management in Europe - Part I - (Sep 22, 2010) - Basel
|
Building the eCTD: Practical Solutions to Compile Electronic Submissions - (Sep 23, 2010) - Basel
|
Clinical Statistics for Nonstatisticians - (Sep 27, 2010) - Horsham
|
Advanced Clinical Statistics for Non-Statisticians - (Sep 29, 2010) - Horsham
|
Regulatory Affairs Part II: The NDA Phase - (Oct 04, 2010) - Horsham
|
Practical GCP Compliance Auditing of Trials & Systems - (Oct 06, 2010) - London
|
Utilizing Chemistry, Manufacturing & Control (CMC) in Drug Development - (Oct 07, 2010) - Horsham
|
How to Prepare for a Safety Inspection - (Oct 15, 2010) - Horsham
|
US Regulatory Affairs - (Oct 18, 2010) - Prague
|
Leadership Experience - (Oct 18, 2010) - San Diego
|
Essentials of Project Management - (Oct 18, 2010) - Horsham
|
New Drug Product Development & Lifecycle Management - (Oct 19, 2010) - Horsham
|
Enterprise Resource Planning - (Oct 21, 2010) - Horsham
|
Executing and Controlling Projects - (Oct 21, 2010) - Horsham
|
Excellence in Pharmacovigilance: Clinical Trials and Post Marketing - (Oct 25, 2010) - Vienna
|
Good Management of Medical Devices - (Oct 27, 2010) - Geneva
|
An Introduction to Product Information Management (PIM) - (Oct 28, 2010) - Geneva
|
Pre-marketing Clinical Safety & Pharmacovigilance - (Nov 01, 2010) - Horsham
|
Introduction to Signal Detection and Data Mining - (Nov 03, 2010) - Horsham
|
Post-marketing Drug Safety & Pharmacovigilance - (Nov 04, 2010) - Horsham
|
Introduction to Good Clinical Practices and Auditing - (Nov 08, 2010) - Horsham
|
Regulatory Affairs in Biologics - (Nov 11, 2010) - Horsham
|
Regulatory Affairs Part I: The IND Phase and Part II: The NDA Phase - (Nov 15, 2010) - Baltimore
|
Clinical Project Management - (Nov 15, 2010) - Horsham
|
Project Risk Management - (Nov 18, 2010) - Horsham
|
European Regulatory Affairs - (Nov 18, 2010) - Boulogne-Billancourt (Paris)
|
Advanced GCP Study Monitoring - (Nov 19, 2010) - Prague
|
Practical Guide for Pharmacovigilance: Clinical Trials and Post Marketing - (Dec 01, 2010) - Paris
|
CTD Dossier Requirements: Focus on EU Module 1 and Quality Module 3 - (Dec 05, 2010) - Dubai
|
Overview of Drug Development - (Dec 08, 2010) - Horsham
|
|
|
 Tutorial | |
|
TUTORIAL #3 - Practical Management of eCTD Life Cycle - (Feb 16, 2010) - National Harbor
|
TUTORIAL #4 - XML Pharmaceutical Standards and the Practical Implementation - (Feb 16, 2010) - National Harbor
|
TUTORIAL #5 - My Company Has Decided to Go Paperless… Now What??? - (Feb 16, 2010) - National Harbor
|
TUTORIAL #1 - Creating Compliant Electronic Submissions for the US, EU and Canada - (Feb 16, 2010) - National Harbor
|
TUTORIAL #2 - What EDM Costs Us: Economics and the Realities of Our Technology Investment - (Feb 16, 2010) - National Harbor
|
TUTORIAL #6 - Guidance-compliant eCTDs - (Feb 16, 2010) - National Harbor
|
TUTORIAL: DDMAC and Compliance 101: A Primer - (Feb 22, 2010) - New York
|
Tutorial 14: Recent European Regulatory Key Aspects of Biopharmaceuticals - (Mar 08, 2010) - Monaco
|
Tutorial 15: After the PIP Decision: Modification of the agreed PIP, validation and compliance check - (Mar 08, 2010) - Monaco
|
Tutorial 16: Introduction to EU Medical Device Regulation - (Mar 08, 2010) - Monaco
|
Tutorial 17: Introduction to European Regulatory Affairs - (Mar 08, 2010) - Monaco
|
Tutorial 18: Data Privacy in Clinical Trials and Pharmacovigilance - (Mar 08, 2010) - Monaco
|
Tutorial 19:Referrals to CHMP- How are they handled? - (Mar 08, 2010) - Monaco
|
Tutorial 20: eCTD Submission Compilations for the EU - (Mar 08, 2010) - Monaco
|
Tutorial 21: Health Technology Assessment: everything you ever wanted to know but were too afraid to ask! - (Mar 08, 2010) - Monaco
|
Tutorial 13: The "Quality-by-Design" Initiative – A Look Inside from Multiple Angles - (Mar 08, 2010) - Monaco
|
Tutorial 12: Analysis of Safety Data from Clinical Trials - (Mar 08, 2010) - Monaco
|
Tutorial 02: Hot Topics in Pharmacovigilance in the EU: EudraVigilance Access Policy, International Standardisation Work E2B and Identification of Medicinal Products, Signal Detection, Duplicate Management - (Mar 08, 2010) - Monaco
|
Tutorial 03: Good Vigilance Practices – How do continuous improvement, audits and inspections contribute? - (Mar 08, 2010) - Monaco
|
Tutorial 04: From Present to Future: PSUR regulatory and scientific challenges - (Mar 08, 2010) - Monaco
|
Tutorial 05: Operation of European Registration Procedures: Centralised, Mutual Recognition and Decentralised Procedures - (Mar 08, 2010) - Monaco
|
Tutorial 07: Qualified Person for Pharmacovigilance (QPPV): What Do You Need to Know? - (Mar 08, 2010) - Monaco
|
Tutorial 06: Interactions between the Regulatory Regime and the Legal Principles Governing Intellectual Property, Competition, and Product Liability for Non-Lawyers - (Mar 08, 2010) - Monaco
|
Tutorial 08: Adaptive Designs for Confirmatory Clinical Trials - (Mar 08, 2010) - Monaco
|
Tutorial 09: Implementation of the EU Variation Regulation: Why – When – What - (Mar 08, 2010) - Monaco
|
Tutorial 10: Orphan Drugs in the EU; From Designation to Marketing Authorisation - (Mar 08, 2010) - Monaco
|
Tutorial 11: Signal Detection Methods for Beginners – Overview and Case Studies - (Mar 08, 2010) - Monaco
|
Core Curriculum - (Mar 14, 2010) - Scottsdale
|
TUTORIAL #1 - Evidence-Based Medicine: Trials and Tribulations - (Mar 14, 2010) - Scottsdale
|
TUTORIAL #2 - Pithy Prose and Deft Discovery: Not Just Another Writing and Searching Course for the Medical Communications Professional - (Mar 14, 2010) - Scottsdale
|
TUTORIAL #3 - Medical Science Liaison Forum 2010 - (Mar 14, 2010) - Scottsdale
|
TUTORIAL #4 - A Review in Practical Applications of Biostatistics - (Mar 14, 2010) - Scottsdale
|
|
|
 Webinar | |
|
WEBINAR: Progression-Free Survival Oncology Webinar 4-Part Series – Part 3: Handling Missing/Censored Observations and Statistical Evaluation of PFS (Analysis of PFS) - (Feb 09, 2010) - Online
|
WEBINAR: CMC Issues and 505(b)(2) Submissions - (Feb 10, 2010) - Online
|
WEBINAR: Do Subvisible Particles Contribute to the Immunogenicity of Therapeutic Proteins? - (Feb 11, 2010) - Online
|
WEBINAR: Progression-Free Survival Oncology Webinar 4-Part Series - Part 4: Regulatory Considerations: Lessons Learned and Path Forward - (Feb 16, 2010) - Online
|
WEBINAR: Regulatory Strategies in Latin America: New Conquest for Pharmaceutical Companies for Timely Submissions and Project Start-Ups - (Feb 17, 2010) - Online
|
WEBINAR: Opioid Class REMS: What’s It All About? - (Feb 18, 2010) - Online
|
WEBINAR: Expanding Clinical Research Beyond Borders: The Importance of Latin America - (Feb 24, 2010) - Online
|
WEBINAR: FDA-CDER Discusses Activities to Reduce Preventable Medication Harm: REMS, Medication Errors, and Safe Use - (Mar 19, 2010) - Online
|
WEBINAR: eCTD 101: An Overview and its Impact on the Regulatory Submissions Process - (Mar 30, 2010) - Online
|
Basics of an IND - 6 Part Online Training Series - (May 03, 2010) - Online
|
Overview of Drug Development from Discovery through Marketing Application - 3-Part Online Training Series - (May 11, 2010) - Online
|
Basics of the NDA - Six-Part Online Training Series - (May 17, 2010) - Online
|
Basics of Interactions with FDA during the IND/NDA Phases - Two-Part Online Series - (Jun 02, 2010) - Online
|
Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Online Training Course - (Jun 04, 2010) - Online
|
Clinical Statistics for Nonstatisticians - 5-Part Online Training Series - (Jul 12, 2010) - Online
|
Computer Systems Validation for the Non-computer Professional Online Training Series - (Jul 19, 2010) - Online
|
Fundamentals of Project Management for the Non-project Manager - 4-Part Online Training Series - (Aug 09, 2010) - Online
|
Development of a Clinical Study Report - 3-Part Online Training Series - (Sep 16, 2010) - Online
|
Good Clinical Practices for the Clinical Research Professional - 4 Part Online Training Series - (Oct 12, 2010) - Online
|
Contributing to High-performance Biopharm Teams - 6 Part Online Training Series - (Oct 28, 2010) - Online
|
Who's Monitoring the Monitor - 3-Part Online training Series - (Nov 05, 2010) - Online
|
|
|
 Webinar Archive | |
|
ARCHIVED - Core Safety Profile and Labeling Harmonization in the European Union - (Feb 09, 2010) - Online
|
ARCHIVED - How to Ensure Legally Admissible and Compliant Digital Signatures and Identities - (Feb 09, 2010) - Online
|
ARCHIVED - Why You Need to Know About the EDM Reference Model - (Feb 09, 2010) - Online
|
ARCHIVED - Pharmacovigilance for Generics: Challenges and Strategies - (Feb 09, 2010) - Online
|
ARCHIVED - Clinical Trial Landscape in India Webinar Series – Part 3 -Ethical Issues in Clinical Trials in Individuals with Reduced Autonomy - (Feb 09, 2010) - Online
|
ARCHIVED - Key Components of the EU Risk Management Plan (RMP) and US Risk Evaluation and Mitigation Strategy (REMS) - (Feb 09, 2010) - Online
|
ARCHIVED - How Strategic Partnerships Can Accelerate Pandemic Flu Vaccine Development - (Feb 09, 2010) - Online
|
ARCHIVED - Use of Foreign Trial Data for NDA Approval - (Feb 09, 2010) - Online
|
ARCHIVED - Medical Communications: A Focus on Quality and Compliance - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: New REMS Draft Guidance Issued by FDA - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Safety and Ethical Emerging Issues Impacting Patient Recruitment and Retention - (Feb 09, 2010) - Online
|
- (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Innovative Medicines Initiative - Better Tools for Better Medicines - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Global Perspective on What Sites Need from Sponsors and CRO's - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Post Approval Changes (Variations) in the European Union Focusing on CMC - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Statistical Methods for Interval Censored Data - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: C-Path’s Predictive Safety Testing Consortium Status: Updates on Novel Kidney, Liver, and Skeletal Muscle Safety Biomarkers - (Feb 09, 2010) - Online
|
ARCHIVED - Generic Biologics: Separating Science Fact from Science Fiction - (Feb 09, 2010) - Online
|
ARCHIVED - Regulated Product Submissions (RPS) Promise and Progress - (Feb 09, 2010) - Online
|
ARCHIVED - Wyeth v. Levine: Understanding the U.S. Supreme Court's Recent Failure-to-Warn Preemption Case - (Feb 09, 2010) - Online
|
ARCHIVED - FDA Discusses Sentinel Initiative - (Feb 09, 2010) - Online
|
ARCHIVED: The New Look at eCTD Lifecycle Management: How Mapping from NDA to IND can Streamline Submission Lifecycle Chores - (Feb 09, 2010) - Online
|
Archived - Electronic Submission Gateway Update - (Feb 09, 2010) - Online
|
ARCHIVED - Overview of Meta-Analysis Including Analysis of Rare Adverse Event Data - META-ANALYSIS WEBINAR SERIES (Part 1) - (Feb 09, 2010) - Online
|
ARCHIVED - Part 2 -META-Analysis of Observational Data - META-ANALYSIS WEBINAR SERIES (Part 2) - (Feb 09, 2010) - Online
|
ARCHIVED - Part 3 - Role of Meta-Analysis in Regulatory Decision Making - META-ANALYSIS WEBINAR SERIES (Part 3) - (Feb 09, 2010) - Online
|
Archived - Regulatory Strategies for Ensuring Compliance in Global Clinical Trials - (Feb 09, 2010) - Online
|
ARCHIVED - European Guidance on Risk Management of Human Pharmaceuticals in Pregnancy and Lactation - (Feb 09, 2010) - Online
|
Novel Approaches for Using Electronic Health Records for Pharmacovigilance - (Feb 09, 2010) - Online
|
Archived - Pharmacovigilance Regulations in India - (Feb 09, 2010) - Online
|
Archived - Proven Strategies for Global Recruitment - (Feb 09, 2010) - Online
|
ARCHIVE - Cost-Effective Adverse Event Case Processing - (Feb 09, 2010) - Online
|
ARCHIVED - Electronic Data Capture: Strategies to Enhance Data Capture, Site Satisfaction and Study Participation - (Feb 09, 2010) - Online
|
Archived - Update on FDA's Good Importer Practices and Pharnaceutical Secure Supply-chain Pilot Program - (Feb 09, 2010) - Online
|
ARCHIVED - FDA and Industry Perspectives on Signal Detection and Data Mining - (Feb 09, 2010) - Online
|
ARCHIVED - Outsourcing: Planning and Managing the Sponsor-provider Relationship - (Feb 09, 2010) - Online
|
Archived - The Evolving role of Project and Alliance Managers at Each Stage of Product Development - (Feb 09, 2010) - Online
|
Archived - Defining and Managing Protocol Deviation/Violation/Exception - (Feb 09, 2010) - Online
|
ARCHIVED - Regulatory Requirements for Conducting Clinical Trials in India - (Feb 09, 2010) - Online
|
ARCHIVED - Recruitment Budget Planning - (Feb 09, 2010) - Online
|
ARCHIVED - Risk Management Strategies and Pharmacovigilance of Opioids and Other Controlled Substances - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Using eClinical Tools to Improve Data Quality - (Feb 09, 2010) - Online
|
ARCHIVED: FDA eDRL Process - (Feb 09, 2010) - Online
|
ARCHIVED: A New Approach to Large Observational Studies: “Local Control” Approach to Analysis - (Feb 09, 2010) - Online
|
ARCHIVED: Critical Path Webinar Series- Part 1 - Standards for Emerging Biomarkers - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Update on the Revised European Labeling Guideline – European Summary of Product Characteristics - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Patient-reported Outcome Measures: Announcing the Final FDA PRO Guidance - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Pharmacovigilance Guidance in Relation to Social Web-Based Media - (Feb 09, 2010) - Online
|
ARCHIVED WEBINAR: Pharmacovigilance from the Medical Writer Perspective - (Feb 09, 2010) - Online
|
ARCHIVED - Choosing the Appropriate Electronic Data Capture Hosting Model - (Feb 09, 2010) - Online
|
ARCHIVED - Cardiac Safety Issues in Early Drug Development - (Feb 09, 2010) - Online
|
ARCHIVED - Registries and Safety - (Feb 09, 2010) - Online
|
ARCHIVED - Communication Fundamentals for Clinical Trial Success: Mastering the DM Language - (Feb 09, 2010) - Online
|
ARCHIVED - Clinical Trial Landscape in India Webinar Series – Part 1 -Worldwide Regulatory Landscape: Current Regulatory Initiatives in the US, Canada and EU - (Feb 09, 2010) - Online
|
ARCHIVED - Pre-marketing Strategies for Central Nervous System (CNS) Drugs - (Feb 09, 2010) - Online
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|